US Files Complaint Against Gilead Sciences For Patent Infringement
Friday, 8 November 2019 () The United States government has filed a lawsuit against Gilead Sciences, alleging that the company's two HIV drugs, Truvada and Descovy, infringe on four patents owned by the Department of Health and Human Services or HHS. According to the Department of Justice, the four patents owned by the HHS cover specific drug regimens used for pre-exposure prophylaxis or PrEP, to prevent HIV infection.
FDA Approves Second HIV Prevention Treatment. The pre-exposure prophylaxis (PrEP) is called Descovy. It was developed by Gilead Sciences. As a PrEP drug, Descovy is meant to be taken daily. PrEP drugs..